Latest Regulatory Compliance News

West African Resources Limited has unveiled an updated 10-year gold production plan, projecting a peak output of 569,000 ounces in 2029 supported by 12.2 million ounces in Mineral Resources and 6.5 million ounces in Ore Reserves.

Mayne Pharma has firmly rejected a fresh termination notice from Cosette Pharmaceuticals alleging breaches related to FDA disclosure, escalating an ongoing contractual dispute with significant legal implications.

BlackRock Investment Management (Australia) Limited has announced the Distribution Reinvestment Plan (DRP) prices for three major Australian iShares ETFs for the July 2025 distribution period, alongside important investor compliance reminders.

BlackRock Investment Management (Australia) Limited has announced confirmed cash distributions for three Australian iShares ETFs, with payments scheduled for mid-August 2025. The announcement also highlights investor obligations around tax certification and promotes sustainable communication practices.

Orcoda Limited has clarified the materiality and timing of disclosures related to its ACTA trial and new SaaS contracts, confirming compliance with ASX Listing Rules and explaining the rationale behind its announcements.

ChemX Materials Limited has explained the delayed filing of director interest notices, attributing it to transitional challenges during its recent recapitalisation and governance overhaul.

Lincoln Minerals Limited has announced a pro-rata renounceable entitlement issue to raise approximately $1.5 million, partially underwritten by Mahe Capital Pty Ltd, to fund exploration across multiple projects including copper, uranium, graphite, and magnetite.

Credit Corp Group delivered a robust FY25 with a 16% increase in net profit after tax, driven by US debt buying and Australian/NZ lending growth. The company sets an ambitious FY26 outlook, underpinned by a record US investment pipeline and new product launches.

Lakes Blue Energy has extended the closing date of its Cleansing Prospectus Offer to November 5, 2025, aiming to smooth the path for secondary trading of new shares.

Leeuwin Metals Ltd has addressed a sudden spike in its share price and trading volume, confirming no undisclosed material information exists and attributing the movement to external market factors and a new research report.

Alterity Therapeutics faces ASX scrutiny after mistakenly marking multiple announcements as market sensitive, prompting a review of its disclosure practices. The biotech denies any intent to manipulate its share price despite repeated errors.

Domain Holdings Australia has updated its announcement to correct the lodgement date of court orders critical to its special dividend tied to the CoStar acquisition scheme.